Australia markets close in 4 minutes

Tonix Pharmaceuticals Holding Corp (TPM.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.3600-0.0130 (-3.49%)
At close: 07:04PM CET
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
79,498
68,838
36,157
18,192
17,558
Selling general and administrative
29,344
23,474
14,354
10,636
8,764
Total operating expenses
108,842
92,312
50,511
28,828
26,322
Operating income or loss
-108,842
-92,312
-50,511
-28,828
-26,322
Income before tax
-108,091
-92,287
-50,463
-28,618
-26,089
Income from continuing operations
-108,091
-92,287
-50,463
-28,618
-26,089
Net income
-108,091
-92,287
-50,463
-28,618
-26,089
Net income available to common shareholders
-112,346
-92,287
-52,174
-31,092
-29,355
Basic EPS
-
-8.32
-17.60
-618.56
-8.58k
Diluted EPS
-
-8.32
-17.60
-618.56
-8.58k
Basic average shares
-
11,257
2,956
50.267
3.421
Diluted average shares
-
11,257
2,956
50.267
3.421
EBITDA
-
-92,262
-50,484
-28,802
-26,268